Headline
The latest stories from AHA Today.
AHA President and CEO Rick Pollack began AHA’s 2024 Annual Meeting remarking on the essential work of hospitals and health systems, as well as the many challenges they are facing, including workforce shortages, underpayment, supply chain issues and cyberattacks.
The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress’ formula for calculating Medicare Disproportionate Share Hospital payments.
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483).
The AHA May 5 will award Mary Beth Kingston, Ph.D., its 2025 Award of Honor during the AHA Annual Membership Meeting in Washington, D.C. Kingston, an outspoken advocate for nurse safety, led efforts to reduce violence against the health care workforce through the AHA and federal government, and…
During the 2025 AHA Annual Membership Meeting in Washington, D.C., the AHA will present Melinda Estes, M.D., former president and CEO of Saint Luke's Health System, and Rod Hochman, M.D., former president and CEO of Providence Health and Services, with its highest honor — the Distinguished Service…
The National Security Agency April 23 released a report on operational technology systems that includes recommendations for security policies and technical requirements for devices installed in national security systems.
A New England Journal of Medicine study published April 27 found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer patients instead of traditional methods such as chemotherapy, radiation or surgery.
There have been 884 confirmed cases of measles nationwide so far this year, with cases reported by 29 states, according to the latest data from the Centers for Disease Control and Prevention.
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride Injection 500mg/100mL Infusion bags due to the products potentially containing inert polypropylene fibers.
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports that included a tip detachment, a vessel rupture and a vasospasm.